Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, ottobre 20
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Organigram Global Inc
OGI
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.9370
-0.0057
-0.6%
Ult. Agg.: Oct 20, 7:24 PM
$0.9300
-0.0127
-1.35%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Dati finanziari
Sentiment
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Organigram Global Financials
Organigram Global (OGI) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
OrganiGram Holdings Q3 Sales $76.413M Beat $67.660M Estimate
OrganiGram Holdings (NASDAQ:OGI) reported quarterly sales of $76.413 million which beat the analyst consensus estimate of $67.660 million by 12.94 percent. This is a 49.41 percent increase over sales of $51.142 million
Benzinga Newsdesk
PRO
Organigram Affirm Global FY2026 Revenue expected to be more than $255.197M vs $241.360M Est
Organigram Global (NASDAQ:OGI) affirm FY2026 Revenue expected to be more than $255.197M vs $241.360M Est
Benzinga Newsdesk
Organigram Says Vape Weakness Pressures Margins
Organigram reports weak Q2 fiscal 2026 results due to vape and pre-roll sales decline, but expects improvement with recent acquisition, operational changes.
Vandana Singh
PRO
Organigram Global FY2026 Revenue expected to be more than $350.000M vs $341.450M Est
Organigram Global (NASDAQ:OGI) FY2026 Revenue expected to be more than $350.000M vs $341.450M Est
Benzinga Newsdesk
PRO
OrganiGram Holdings Q2 EPS $(0.01), Inline, Sales $43.597M Miss $52.060M Estimate
OrganiGram Holdings (NASDAQ:OGI) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 100 percent decrease over earnings of $0.22 per share from the same period last year.
Benzinga Newsdesk
Earnings Scheduled For May 12, 2026
Benzinga Insights